Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?

Natural killer T (NKT) cells constitute a unique subset of innate-like T lymphocytes which differ from conventional T cells by recognizing lipid antigens presented by the non-polymorphic major histocompatibility complex (MHC) I-like molecule CD1d. Despite being a relatively infrequent population of...

Descripción completa

Detalles Bibliográficos
Autores principales: Favreau, Mérédis, Vanderkerken, Karin, Elewaut, Dirk, Venken, Koen, Menu, Eline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029615/
https://www.ncbi.nlm.nih.gov/pubmed/26895468
http://dx.doi.org/10.18632/oncotarget.7440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029615/
https://www.ncbi.nlm.nih.gov/pubmed/26895468
http://dx.doi.org/10.18632/oncotarget.7440

Ejemplares similares